Back to Authors

Song, Jianxun Jim

0000-0002-9734-6176

Mayo Clinic

Pennsylvania State University

Citations 1

Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
Kong, Sinyi, Dong, Hongxin , Thiruppathi, Muthusamy , Lin, Zhenghong , Chini, Eduardo N. , Fang, Deyu , Chini, Eduardo, Song, Jianxun Jim , Prabhakar, Bellur S. , Qiu, Quan, Zhang, Bin

The Journal of Immunology | September 17, 2015 | Volume: 195 | Issue: 8 | Pages: 3685-3693

10.4049/jimmunol.1500713 Get It

Abstract Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.